Research Article
T Cell Response in Patients with Implanted Biological and Mechanical Prosthetic Heart Valves
Table 8
Impact of GI-tract diseases on T cells populations in biological prosthesis recipients.
| | T cells populations | Healthy donors, | GI-tract diseases, | No GI-tract diseases, | value |
| | CD3+% | 78.27 (73.07; 82.52) | 66.98 (62.34; 76.34) | 70.67 (66.32; 76.92) | 1-2
1–3 | | CD3+ abs. | 1419.31 (1126.25; 1735.91) | 1230.80 (941.04; 1526.80) | 1281.15 (1122.01; 1461.93) | n/s | | CD3+CD8+% | 25.80 (20.64; 33.20) | 23.07 (18.02; 25.75) | 26.84 (20.34; 36.02) | 1-2 | | CD3+CD8+ abs. | 462.37 (349.70; 647.87) | 360.40 (280.98; 464.44) | 478.00 (327.14; 701.41) | 1-2 | | CM Tcyt%. | 11.50 (8.70; 16.38) | 6.44 (4.20; 7.94) | 5.59 (3.21; 6.30) | 1-2
1–3 | | CM Tcyt abs. | 51.69 (36.70; 74.30) | 22.28 (13.17; 38.49) | 23.45 (19.23; 29.84) | 1-2
1–3 | | EM Tcyt% | 31.82 (18.80; 43.55) | 32.94 (28.76; 42.60) | 21.75 (13.0; 33.86) | | | EM Tcyt abs. | 122.56 (74.29; 196.04) | 134.98 (116.62; 158.90) | 108.44 (60.61; 147.64) | n/s | | TEMRA Tcyt% | 26.67 (19.58; 34.93) | 46.69 (43.46; 49.49) | 59.60 (42.14; 68.43) | 1-2
1–3 | | TEMRA Tcyt abs. | 104.32 (72.94; 188.42) | 140.19 (129.60; 206.02) | 277.78 (144.12; 461.98) | 1–3 | | N Tcyt% | 24.46 (16.51; 39.58) | 12.06 (8.10; 14.28) | 13.43 (7.45; 25.74) | 1-2
1–3 | | N Tcyt abs. | 98.47 (56.29; 199.74) | 40.57 (26.37; 54.33) | 45.06 (33.97; 106.42) | 1-2
1–3 | | CD3+CD4+% | 48.06 (41.04; 52.58) | 40.74 (36.19; 54.41) | 41.91 (38.31; 45.28) | 1–3 | | CD3+CD4+ abs. | 835.92 (624.17; 1096.10) | 729.64 (579.04; 999.13) | 705.31 (646.06; 882.92) | n/s | | CM Th% | 44.67 (38.42; 49.32) | 44.05 (39.33; 47.82) | 36.15 (34.83; 39.84) | 1–3 | | CM Th abs. | 338.29 (269.64; 484.11) | 330.65 (220.84; 449.51) | 257.76 (245.93; 302.12) | 1–3 | | EM Th% | 24.02 (17.54; 30.71) | 25.64 (18.83; 28.86) | 26.32 (15.97; 32.87) | n/s | | EM Th abs. | 197.64 (150.63; 229.90) | 167.11 (144.86; 233.30) | 166.95 (122.94; 254.08) | n/s | | TEMRA Th% | 0.82 (0.37; 1.67) | 1.49 (0.94; 2.05) | 2.31 (0.97; 4.01) | 1–3 | | TEMRA Th abs. | 6.17 (3.11; 13.58) | 10.34 (6.19; 15.86) | 17.45 (6.58; 33.99) | 1–3 | | N Th% | 29.88 (19.81; 36.00) | 30.67 (24.50; 36.61) | 33.39 (22.49; 41.32) | n/s | | N Th abs. | 222.99 (145.88; 369.81) | 211.18 (140.38; 382.83) | 219.48 (140.96; 326.85) | n/s | | CD4/CD8 | 2.01 (1.34; 2.44) | 2.06 (1.57; 2.98) | 1.55 (1.09; 2.06) | n/s |
|
|
n/s: not significant.
|
